Pharmaceutical giant Eli Lilly's expansion of United States drugmaking real estate is picking up with the completion of a major lab facility near San Diego designed to house up to 15 biotech firms, a move that also marks just the latest major life sciences property investment for the industry across the country.
How Eli Lilly's latest lab growth fuels rising drug industry property investment
Drugmaker extends Gateway Labs in San Diego as real estate expansion picks up
By Lou Hirsh
CoStar NewsOctober 6, 2025 | 3:39 P.M.
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties
- One Alexandria Square
10945 Alexandria Way, San Diego, CA
- Companies
- Eli Lilly & Co.
Manufacturing
- Alexandria Real Estate Equities, Inc.
Real Estate
- JLL
Real Estate
- Contacts
- Greg Bisconti
Executive Managing Director, JLL